Williams Sarah Joanne 4

4 · AN2 Therapeutics, Inc. · Filed Feb 23, 2026

AI-generated summary of this filing

Updated Feb 23, 2026

AN2 (ANTX) Sarah Williams Receives 48,375 RSUs

What Happened

Sarah Joanne Williams, Principal Accounting Officer of AN2 Therapeutics (ANTX), received an award of 48,375 restricted stock units (RSUs) on February 20, 2026. The grant price is listed as $0.00 (award), so immediate cash value is $0. Vesting for this award is 1/4th of the shares annually over four years beginning January 1, 2026, subject to her continued service.

Key Details

Transaction date: 2026-02-20; Filing date: 2026-02-23 (timely filed).
Transaction type/code: Award/Grant (A); shares granted: 48,375; price: $0.00.
Vesting (footnote F1): 25% annually over four years from Jan 1, 2026, subject to continuous service.
Additional footnote (F2): filing also references remaining balances of prior RSUs — 10,938 RSUs vesting annually from Jan 1, 2025, and 11,850 RSUs vesting quarterly from May 28, 2024. From those prior RSUs, 3,174 shares were sold to cover taxes and 814 shares were sold on the open market.
Shares owned after the transaction: not specified in the filing.
Exhibit: Power of Attorney attached.

Context

RSUs are compensatory awards that vest over time; they are not open-market purchases or sales and do not by themselves indicate immediate buying/selling sentiment.
The filing shows routine tax-related share sales from earlier RSU grants (common to cover withholding). No option exercises or open-market purchases were reported in this Form 4.

Form 4

Period: 2026-02-20

Principal Accounting Officer

Transactions

Footnotes (2)

[F1]Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
[F2]Includes the balance of (a) 10,938 RSUs which vest as follows: 1/4th of the RSUs vest in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2025, and (b) 11,850 RSUs which vest as follows: 1/16th of the RSUs vest in substantially equal installments quarterly (rounded down to the nearest whole number of shares) over four years from May 28, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date. A total of 3,174 shares from the aggregate number of the RSUs issued under (a) and (b) above were sold to cover taxes and a total of 814 shares were sold on the open market.

Signature

/s/ Sarah Joanne Williams|2026-02-23

2 files